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Medical Complex, District Headquarter, Benazir Bhutto Women & Children and
Hira General & Teaching Hospitals of Abbottabad. Groundwater Samples were ran-
domly collected from the hospitals and its surrounding areas, tube wells of homes,
taps of hotels, restaurants, cafes and juice stalls and other possible locations. Each
sample collected had two duplicates. Membrane filtration technique (MF) was used
test the samples collected. The study areas i.e. four hospitals and its surroundings
fromwhere the sampleswere collected aremapped and corresponding database of
sample analysis are constructed using GIS software Arc View 3.2. RESULTS: The
mean value of the samples collected from the hospital was 21 colonies/100ml
and that of surrounding area was 128.8 colonies/100ml. The E.coli colonies
found were in the range of 23.5 to 240 colonies per 100ml of water of drinking
water in DHQ. While Benazir Bhutto Women & Children Hospital and Hira hos-
pital the mean value of hospital water samples was 20.33colonies/100ml,
whereas, the surrounding water samples was 121.62colonies/100ml and 39.5
colonies/100ml respectively which indicates the contaminated than the hospi-
tal’s drinking water. CONCLUSIONS: The drinking water being provided in the
four hospitals studied is do not meet the criteria of WHO and Pakistan’s NEQS.
Improper waste management/disposal system, ineffective installation of drinking
water pipelines, lack of Filtration systems are three major reasons poor water
quality. Therefore, proper preventive and corrective measures must be followed
especially in the hospital sector in order to provide value care which patient de-
served. Moreover for the hospital staff which are themajor sources for health care.
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MEDICATION ADHERENCE AND PERSISTENCE FOR HYPOGONDAL PATIENTS
TREATED WITH TOPICAL TESTOSTERONE THERAPY: A RETROSPECTIVE
CLAIMS ANALYSIS
Schoenfeld MJ, Shortridge E, Cui Z, Shen W, Muram D
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OBJECTIVES: The diagnosis of hypogonadism is established in symptomatic
men with consistently low levels of serum testosterone, whether due to specific
diagnoses, such as Klinefelter syndrome, or non-specific diagnoses, which often
occur with aging. Testosterone gels are the most common form of testosterone
replacement therapy for hypogonadism in the United States, but little is known
about patient adherence and persistence with therapy. This study seeks to
examine testosterone gel adherence and persistence among hypogonadism
patients.METHODS: The type of hypogonadism (specific versus non-specific) was
classified using either ICD-9-CM diagnostic codes or testosterone prescription
codes in the Thomson Reuters MarketScan® Database in 2009. Medication persis-
tence was defined as the length of therapy (LOT) from the index date to the earliest
ending date of the last prescription, defined as either the date of the first gap of30
days between prescriptions or the end of study period (12 months). Medication
adherence was measured by medication possession ratio (MPR) in the 6 months
follow-up period. Adherence rate was defined as percent of MPR 0.8. LOT, MPR
and adherence rate were calculated by diagnostic code and age group and com-
pared using t-test or chi-square test. RESULTS: 91,200 men met study criteria for
hypogonadism: 11.1% with specific and 89.9% with non-specific diagnostic codes.
The mean LOT was 196 days and 178 days, respectively (p 0.0001). MPR and ad-
herence rates were similar between men with specific (0.4 and 8.6%, respectively)
and non-specific (0.4 and 9.0%, respectively) diagnoses. LOT, MPR and adherence
rate were numerically similar across all age groups. CONCLUSIONS:Unexpectedly,
diagnostic specificity and age were not found to be key etiologic factors in testos-
terone gel adherence and persistence for hypogonadal men. Unexplored factors
that might provide more sensitivity include other testosterone application meth-
ods, hypogonadal symptom severity, and ascertainment of testosterone levels.
PIH80
THE SOCIOCULTURAL FACTORS AGAINST FERTILITY AMONG KENYAN LUO
TRIBE
Nyabade G
Go Fishnet Youth Project, Kisumu, Nyanza, Kenya
BACKGROUND: The Luo tribe is found along the shore of Lake Victoria in western
Kenya. The majority of the tribe, however, lives in the entire Nyanza provine,
Kenya. Before this study was undertaken, factors related to fertility decisions
among the tribe were not known. OBJECTIVES: This study is aimed at describing
and documenting the sociocultural factors affecting decisions related to fertility
among the Luo tribe. METHODS: The study applied the qualitative research
method. In-depth interviews and focus-group discussions were used as data col-
lection methods. Analysis was done manually. RESULTS: Children among the Luo
were highly valued and desired irrespective of their gender. The ideal family size,
according to most of the respondents, was 24 children. Luo men are polygamous
and can marry more than five wives in order to form large families and fame.
However, it is an abomination among Luo women to fail to get pregnant; a phe-
nomenon they termed lur. Socially a Luo healthy family is known by a big number
of children in a homestead despite the fact that feeding might be a problem
thus,child-spacing was never related to child welfare and maternal well-being.
Methods for child-healthywelfare included prolonged breastfeeding dhodho nyadhi,
ornaments in various forms and shapes, spiritual invocations and dried herbs
Nyamrerwa. Few Luo women practiced modern methods of family planning.
CONCLUSIONS: Trends in fertility and wellbeing among the Luo tribe need to be
monitored regularly and appropriate measures be taken to introduce and promote
modern family planning and child health services to ensure a healthier family life.
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OBJECTIVES: To evaluate the perception of nurses towards the role of pharmacist
in Pakistan’s health care system. METHODS: A qualitative approach was used to
gain the understanding of nurses perception regarding the role of pharmacist. The
study took place at AMCHospital of Pakistan, from September 2011 until December
2011.Interview were conducted using a semi-structured interview guide which
been developed after extensive literature review. A total of 12 Nurses were inter-
viewed. All the interviews were transcribed verbatim and thematically analyzed
for its content. RESULTS: Thematic content analysis yielded six major themes: 1)
Storage of medicines by pharmacist; 2) Lack of interaction; 3) Seeking help from
pharmacists; 4) Reducework burden in professional duties; 5) Perception regarding
pharmacists’ role; and 6) Participation of pharmacists for pharmaceutical care ac-
tivity. As far as the role of hospital pharmacist is concerned, all the nurses high-
lighted the importance of having a pharmacist in hospital in order to improve
current practice and professional image. They were quite confident and agreed
with respect to the presence of pharmacist to improve to improve the medication
use among the patients. At present nurses belief that by incorporating the role of
pharmacist in patient care, the worth of nurses would be far little as compared to
what it is now and can result interference into their duties. CONCLUSIONS:Nurses
in Pakistan do consider pharmacist as drug information expert but overall a nega-
tive perception was found toward the role of pharmacist in health care setup. As
because pharmacist was identified as a drug expert and his skills were confounded
only to the issues concerning pharmacy management main cause behind this
behavior may be was the minimal interaction between the two professions.
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HEALTH CARE SCREENING AND PREVENTIVE PRACTICES AMONG WOMEN IN
THE UNITED STATES BY RACE/ETHNICITY
McDonald M, Pickart FD, Zhou J, Mardekian J
Pfizer, Inc., New York, NY, USA
OBJECTIVES: Current knowledge of screening and preventive practices among
women in the United States is incomplete. This study examines current national
estimates for flu and pneumonia shots, colonoscopy/sigmoidoscopy, mammo-
grams, and Pap tests among women in the United States by race/ethnicity.
METHODS: Cross-sectional observational study design. Analysis of nationally rep-
resentative data collected from women participating in the National Health and
Nutrition Examination Survey (NHANES) 2007- 2008 (total women aged 20 years
and older, n3025; non-Hispanic white, n  1366; non-Hispanic black, n 639;
Hispanic, n902; other races, n118). RESULTS: Black and Hispanic women 50
years and older are significantly less likely to receive a flu shot than white women,
45.4% (p0.0001) and 43.3% (p0.0001) versus 56.7%, respectively. 55.1% of women
of other races have received a flu shot in the past year. White women had the
highest rate of pneumonia vaccination (42.7%) and black, Hispanic and other
women had significantly lower coverage; 34.0% (p0.0001), 28.1% (p0.0001), and
29.6% (p0.0001), respectively. The highest screening rate for colon cancer is
among white women (56.2%), followed by black women (51.3%, p0.0005), women
of other races (43.5%, p0.0001), and Hispanic women (39.2%, p0.0001). Age-stan-
dardized mammogram screening rates among whites, black, Hispanics and others
are 75.9%, 78.7%, 75.2% and 74.5%, respectively. Among women 20 years and older,
black and Hispanic women are more likely to have had a Pap test than white
women, 86.6% (p0.0004) and 84.7% (p0.005) vs. 83.5%, respectively. A total of
81.7% of women of other races have had a Pap test. CONCLUSIONS: Age-standard-
ized screening rates for mammograms and Pap tests are high among US women,
regardless of race/ethnicity. However, black, Hispanic and women of other races
are less likely than white women to have received a flu or pneumonia vaccination
in the last year. Effective approaches are recommended to reduce disparities in
health care screenings and prevention practices.
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HEALTH TECHNOLOGY ASSESSMENT IN CHILD HEALTH
Ungar W
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BACKGROUND: While health technology assessment (HTA) increasingly informs
allocative decision-making, the extent to which HTA can be applied to children
demands scrutiny. Pediatric economic evaluation is complicated by dependency
on parents, specific disease characteristics, and dynamic states of cognitive, emo-
tional, and physical development. Chronic disease is rare in children, leading to
difficulties in conducting trials and establishing evidence. Since disabilities that
start in childhood may be carried into adulthood, it is also important to measure
long-term costs and consequences. Long-term datamay not be available ormay be
uncertain. Furthermore, assessments in children must consider externalities in-
cluding parent productivity losses, family quality of life decrements, impacts on
school performance and education, and effects on future employment. Pediatric
HTA must also take into account impacts on non-health sectors, including educa-
tion and social services.OBJECTIVES:Tounderstand the evidence gap in childHTA.
METHODS: The Centre for Reviews and Dissemination database was searched for
pediatric reports published from 2003-2008. Of 147 reports, 84% came from Europe
or North America. The most common intervention category was screening pro-
grams (18%), such as for conditions related to hearing, vision, or speech impair-
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ment, cystic fibrosis, hematologic-metabolic syndromes, overweight, and psycho-
social problems. A comparison between adult and pediatric HTAs was undertaken
for 222 reports published in 2007-2008. RESULTS:Whereas the most common con-
ditions studied in adults were cancer, cardiovascular disorders and rheumatologi-
cal disorders, diseases most commonly studied in children were asthma, autism,
cystic fibrosis and diabetes. In addition to differences between adults and children
related to measurement, analysis and the availability of evidence, the social, legal
and ethical issues that influence decision-making are unique for children due to
their vulnerability and lack of autonomy. CONCLUSIONS: As HTA increasingly
becomes the basis for decision-making, the challenges in applying HTA to child
health must be considered to ensure equity in health care policy.
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PRACTICAL CONSIDERATIONS FOR ESTIMATING SAMPLE SIZE AND STUDY
DURATION IN PREGNANCY EXPOSURE REGISTRIES
Covington D, Churchill P, McKain L
PPD, Wilmington, NC, USA
OBJECTIVES: Pregnancy exposure registries are important tools to evaluate drug
safety in pregnancy. Because pregnancy registries are unique, they present chal-
lenges in estimating critical factors impacting sample size and study duration,
including accrual, retention, and live birth (LB) rates. The objective of this study is
to examine these 3 factors in ongoing pregnancy registries and estimate impact on
sample size and enrollment duration. METHODS: We examined published data
from pregnancy registries identified through the internet and literature searches.
Of the 58 pregnancy registries identified, 21 (36%) had published data available. Of
the 21, only 18 published sufficient detail to allow calculation of LB, retention, and
accrual rates. RESULTS: The average duration for registries with published data
available was 8.8 years compared to 2.7 years for registries with no published data.
Themedian LB rate for single-drug registries was 88% (range: 62-95%), which is 45%
higher than the population rate. The median retention rate was 73% (range: 37%-
99%). The median accrual per year was 81.9 (range: 5.3-296). Using the median
rates, 422 pregnancies would need to be enrolled over 5 years to achieve sufficient
power to rule out a twofold increase in risk of birth defects. The rates varied from
a low of 320 pregnancies enrolled over 1.1 years to a high of 570 pregnancies en-
rolled over 100 years. Factors impacting the variability of rates included drug indi-
cation, patient population, design, data source, location, and recruitment and re-
tention activities. CONCLUSIONS: The LB rate was the least volatile of the factors
examined and the accrual ratewas themost volatile. Using the observed rates from
other pregnancy registries as a guide may aid in determining sample size and
enrollment timelines, but these rates are highly variable. Careful consideration
should also be given to factors that could impact these rates.
INDIVIDUAL’S HEALTH – Research on Methods
PIH85
THE DISABILITY AND QOL WITH THE ELDERLY
Tazaki M, Yamaguchi T
TOHO University, Tokyo, Japan
OBJECTIVES: The aims of this research were 1) to develop the Japanese version of
the World Health Organization Disability Assessment Schedule II (WHODAS II),
which was created to evaluate levels of disabilities based on the International
Classification of Functioning; 2) to evaluate the psychometric properties of the
instrument to check its validity and reliability; 3) to evaluate its applicability to the
elderlywith andwithout disabilities. In this study, a proxy-administered version of
36-items, an interviewer-administered version of 36-items, and the WHO Quality
of Life (QOL) were delivered.METHODS: At first, the preliminary Japanese version
of the WHODAS II was produced after incorporating feedback from a qualitative
study. Then, a preliminary study was conducted with 45 elderly people over 65
years old with various disabilities at two nursing homes in Tokyo (interviewer
administered) and with 30 professional caregivers at the homes (proxy
administered). RESULTS: The number of participants in the interview version of
the assessment was 45 (male 10: female 35), with a mean age of 80.7 (SD 7.3). The
mean age of the elderly who was cared for by those professional care givers who
answered the proxy versionwas 86.1(SD 6.8). The globalWHODAS IImean score for
the proxy-administered group was 100.5 (SD  31.0), and for the interviewer-ad-
ministered group was 58.5 (SD  19.8). The recommended standard Cronbach’s
alpha coefficient for each domain of the WHODAS II was achieved. For the inter-
viewer-administered group, there was a moderately strong, negative correlation
between the QOL score and theWHODAS score (r -0.62, P 0.01). CONCLUSIONS:
It was found that the Japanese version of the WHODAS II has sufficient reliability,
validity, and applicability for use with elderly with various disabilities, and it was
also found that the more severe the disability, the lower the QOL.
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ADVANCED DISEASE IN OVARIAN CANCER: CLINICAL AND ECONOMIC
OUTCOMES WITHIN HOSPITAL INPATIENT SETTINGS
Tate WR, Skrepnek GH, Alberts DS
The University of Arizona, Tucson, AZ, USA
OBJECTIVES: To assess the characteristics of inpatient mortality and charges as-
sociated with advanced disease in ovarian cancer in the United States from
2005-2009. METHODS: Nationally-representative hospital discharge records from
Agency for Healthcare Research and Quality (AHRQ) Healthcare Cost and Utiliza-
tion Project (H-CUP) Nationwide Inpatient Sample (NIS) from 2005-2009 were used
in this retrospective cohort analysis. Cases18 years of agewith advanced ovarian
cancer were selected. Variables analyzed included sites of metastases, patient de-
mographics, hospital characteristics, lengths of stay, primary payer, and Elix-
hauser comorbidity risk-adjustment. Outcomes of mortality and charges were as-
sessed via multivariate logistic and gamma regression, respectively, yielding odds
ratios (OR) or exponentiated beta coefficients (exp(b)). RESULTS: Overall, 352,319
inpatient ovarian cancer cases were observed from 2005-2009, with an inpatient
mortality rate of 5.3% and a national bill of $13.1 billion. Advanced disease repre-
sented 50.5% of cases, averaging 64.1 (13.4) years of age, an inpatient mortality
rate of 7.2%, and average charges of $46,123 (60,396) or 61.1% of the national bill.
The most commonmetastatic sites were gastrointestinal (60.5%), lung/respiratory
(15.4%), liver/digestive organs (18.4%), lymph (11.9%), and genitourinary (4.4%).
Multivariate analyses indicated significantly (p0.05) higher odds of inpatientmor-
tality with metastases to the liver/digestive organs (OR1.28), lung/respiratory
tract (OR1.66), central nervous system (OR1.62), and kidney (OR1.84). Other
key comorbidities associated with increased inpatient mortality included heart
failure, coagulopathy, liver disease, fluid/electrolyte disorders, neurological disor-
ders, pulmonary circulation disorders, renal failure, and weight loss. Significantly
higher inpatient charges were found with metastases to the skin (exp(b)1.13),
liver/digestive organs (exp(b)1.03), gastrointestinal tract (exp(b)1.25), lymph
nodes (exp(b)1.23), and genitourinary system (exp(b)1.21). CONCLUSIONS: Ad-
vanced disease is found in approximately half of inpatient ovarian cancer cases,
incurring a large burden of illness. The increased understanding ofmetastatic sites
and complications remains imperative to improving treatment and patient out-
comes.
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DEPRESSION TREATMENT IN INDIVIDUALS WITH PHYSICAL ILLNESSES: A
COMPARISON BETWEEN CANCER AND CARDIO-METABOLIC CONDITIONS
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OBJECTIVES: Similar challenges are encountered in management of depression
among individuals with cancer and cardio-metabolic conditions; with presence of
high prevalence of diagnosed depression, negative impact of depression on health
outcomes, and competing demands in clinical care encounters, in both the condi-
tions. Additionally, there has been a lack of robust evidence from clinical trials on
the effectiveness of depression treatment on physical illness outcomes in both
cancer and cardio-metabolic conditions. Thus the objectives of this study were to
compare depression treatment rates among individuals with self-reported depres-
sion and cancer or cardio-metabolic conditions, and to examine the association
between depression treatment and presence of cancer diagnosis after controlling
for demographic, socio-economic, access to care, health status, and lifestyle
characteristics.METHODS: The study used a retrospective cross-sectional design.
Data from multiple years of the Medical Expenditure Panel Survey (MEPS), a na-
tionally representative household survey on healthcare utilization and expendi-
tures was used. Study sample consisted of adults aged 21 or older with self-re-
ported depression and cancer (N  528), or self-reported depression and diabetes,
heart disease or hypertension (N  1643). Depression treatment comprised of any
use of antidepressants and/or any use of mental health counseling services.
RESULTS:Treatment rates for depressionwere 78.0% and 81.7% among individuals
with cancer and cardio-metabolic conditions, respectively. After controlling for
demographic- and socio-economic characteristics, access to care, health status,
lifestyle risk factors, and number of physician visits; individuals with cancer were
less likely to report treatment for depression (AOR 0.67; 95% Confidence Interval
((0.49, 0.92), p  0.01) compared to individuals with cardio-metabolic conditions.
CONCLUSIONS: Our findings suggest that presence of cancer may be associated
with a lower likelihood of receiving depression treatment, perhaps due to cancer
being a clinically dominant condition.
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RELATIONSHIP BETWEEN COMORBIDITIES AND LATE-STAGE PROSTATE
CANCER DIAGNOSIS AMONG MEN IN FLORIDA
Xiao H1, Tan F2, Gwede C3, Goovaerts P4, Huang Y5, Ali A1, Adunlin G1
1Florida A&M University, Tallahassee, FL, USA, 2Indiana University-Purdue University,
Indianapolis, IN, USA, 3Moffitt Cancer Center, Tampa, FL, USA, 4BioMedware, Inc, Ann Arbor,
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OBJECTIVES:Comorbidity impacts the treatment options and prognosis of prostate
cancer. This study examined association of major types of comorbidity with late-
stage prostate cancer in Florida.METHODS: The studywas a retrospective analysis
of Florida Cancer Registry data. A total of 60,497 prostate cancer cases diagnosed
between 2001-2007 were included. Individual-level data included demographics,
primary health insurance payer and tumor stage at diagnosis. Census-tract level
data included socioeconomic status extracted from Census 2000 and linked to
individual cancer data. County-level provider-to-case ratio was computed based
on data files provided by the Florida Department of Health. Comorbidity was com-
puted following Elixhauser Index. Multi-level logistic regressionwas used to exam-
ine associations of these factors with late-stage prostate cancer diagnosis.
RESULTS: Among individual level factors, late-stage diagnosis was significantly
and independently associated with being black, unmarried, current smoker, unin-
sured, and presence of comorbidities. No associationwas found between late-stage
diagnosis and year of diagnosis except for 2006. People with public insurance and
diagnosed in hospitals were associated with lower likelihood of late-stage diagno-
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